BUY Granules India — Osho Krishan, Angel One
byOsho Krishan, Angel OneHorizon: 1–3 months30 Jun 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Granules India Limited has secured sole first-to-file ANDA status for Sodium Oxybate Extended-Release for Oral Suspension.
NSE · Press Release·6 Jul · today
1 other SEBI-registered advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·1 Jul · 4d ago
1 advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·29 Jun · 6d ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Granules India
- BUY — Vikas Sethi, Sethi Finmart22 Oct 2026 · ~3 months · target ₹845 · Active
- BUY — Vikas Sethi, Sethi Finmart15 Oct 2026 · ~1 year · target ₹1,000 · Active
- BUY — IDBI Capital7 Oct 2026 · ~2 weeks · target ₹878 · SL hit
- BUY — Aastha Jain, Hem Securities7 Oct 2026 · Same day · target ₹875 · Expired
- BUY — Ansh Jogendra Bhilwar7 Oct 2026 · Same day · target ₹921 · Expired
More from Osho Krishan, Angel One
- BUY Emcure Pharmaceuticals23 Oct 2026 · ~2 weeks · target ₹1,840 · Active
- BUY Anand Rathi Wealth23 Oct 2026 · ~2 weeks · target ₹2,350 · Active
- BUY The Indian Hotels Company22 Oct 2026 · ~2 weeks · target ₹830 · Active
- BUY The Indian Hotels Company22 Oct 2026 · ~3 months · target ₹800 · Active
- BUY SAGILITY22 Oct 2026 · ~2 weeks · target ₹47 · Active

